{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:57:41Z","timestamp":1790989061074,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024MH281"],"award-info":[{"award-number":["ZR2024MH281"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168433","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:13:44Z","timestamp":1788448424000},"page":"168433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PSMD14 promotes hepatocellular carcinoma cell proliferation through E2F4-dependent PHF5A transcription and alternative splicing"],"prefix":"10.1016","volume":"1873","author":[{"given":"Cai","family":"Meijuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiufeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yahao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Junling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168433_bb0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/hepr.13181","article-title":"Novel approaches for molecular targeted therapy against hepatocellular carcinoma","volume":"48","author":"Eso","year":"2018","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbadis.2026.168433_bb0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1874467215666221010092825","article-title":"Prevalence of hepatocellular carcinoma in men and the contribution of androgen and its receptor in pathogenesis and therapy","volume":"16","author":"Abdel-Hamid","year":"2023","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168433_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmp.2025.11.002","article-title":"MIAT, HEIH, and HOTAIR: A novel LncRNA signature in non-metastatic hepatocellular carcinoma patients","volume":"18","author":"Ismail","year":"2025","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168433_bb0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/curroncol30020105","article-title":"Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma","volume":"30","author":"Kumar","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbadis.2026.168433_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143629","article-title":"Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma","volume":"15","author":"Guerra","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2026.168433_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010140","article-title":"Novel molecular targets for hepatocellular carcinoma","volume":"14","author":"Cavalluzzo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2026.168433_bb0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s13046-019-1412-8","article-title":"Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168433_bb0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5306\/wjco.v11.i8.589","article-title":"Novel molecular targets in hepatocellular carcinoma","volume":"11","author":"Chow","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2026.168433_bb0045","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/1120009X.2021.1955202","article-title":"Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms","volume":"34","author":"Dahiya","year":"2022","journal-title":"J. Chemother."},{"key":"10.1016\/j.bbadis.2026.168433_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41388-023-02905-1","article-title":"PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERalpha","volume":"43","author":"Yang","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168433_bb0055","article-title":"PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and Pancreatic Cancer Progression","volume":"12","author":"Lu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bbadis.2026.168433_bb0060","first-page":"813","article-title":"PSMD14-mediated PFKFB2 deubiquitination activates H3K27 lactylation to drive cancer stemness in gastric adenocarcinoma","volume":"4","author":"Zhao","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2026.168433_bb0065","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1038\/ncomms9704","article-title":"POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168433_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2019.10.025","article-title":"Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2","volume":"469","author":"Lv","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2026.168433_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41419-025-07416-3","article-title":"PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1","volume":"16","author":"Lu","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168433_bb0080","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.21037\/tcr-22-218","article-title":"E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma","volume":"11","author":"Tan","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168433_bb0085","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3892\/or.2014.2968","article-title":"Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma","volume":"31","author":"Zeng","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2026.168433_bb0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1186\/s12885-020-07529-2","article-title":"Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data","volume":"20","author":"Zeng","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2026.168433_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164129","article-title":"Uncovering novel roles of miR-122 in the pathophysiology of the liver: potential interaction with NRF1 and E2F4 signaling","volume":"15","author":"Paluschinski","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2026.168433_bb0100","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.febslet.2008.07.009","article-title":"PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma","volume":"582","author":"Wang","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2026.168433_bb0105","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1053\/j.gastro.2010.01.007","article-title":"Proliferative suppression by CDK4\/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells","volume":"138","author":"Rivadeneira","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2026.168433_bb0110","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.7150\/jca.53708","article-title":"E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3","volume":"12","author":"Liu","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168433_bb0115","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.7150\/ijbs.97861","article-title":"NUCB2 promotes hepatocellular carcinoma cell growth and metastasis by activating the E2F4\/PTGR1 axis","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2026.168433_bb0120","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/neuonc\/noy207","article-title":"ECT2\/PSMD14\/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1","volume":"21","author":"Zhi","year":"2019","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2026.168433_bb0125","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1111\/cas.70064","article-title":"PSMD14\/E2F1 Axis-Mediated CENPF Promotes the Metastasis of Triple-Negative Breast Cancer Through Inhibiting Ferroptosis","volume":"116","author":"Zhou","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2026.168433_bb0130","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1038\/s41388-024-03184-0","article-title":"NSUN2 regulates Wnt signaling pathway depending on the m5C RNA modification to promote the progression of hepatocellular carcinoma","volume":"43","author":"Xing","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168433_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1772310","article-title":"Recent advances in m6A RNA modification in hepatocellular carcinoma: from mechanisms to therapeutic potential","volume":"13","author":"Shi","year":"2026","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbadis.2026.168433_bb0140","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","article-title":"The spliceosome: design principles of a dynamic RNP machine","volume":"136","author":"Wahl","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168433_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115857","article-title":"Plant homeodomain-finger protein 5A: A key player in cancer progression","volume":"169","author":"Diaba-Nuhoho","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2026.168433_bb0150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1186\/s12885-024-12620-z","article-title":"Comprehensive analysis of PHF5A as a potential prognostic biomarker and therapeutic target across cancers and in hepatocellular carcinoma","volume":"24","author":"Cheng","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2026.168433_bb0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ebiom.2019.01.058","article-title":"POH1 contributes to hyperactivation of TGF-beta signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-beta receptors and caveolin-1","volume":"41","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbadis.2026.168433_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216526","article-title":"POH1 induces Smad3 deubiquitination and promotes lung cancer metastasis","volume":"582","author":"Yuan","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2026.168433_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3761858","article-title":"Immunogenomic landscape analysis of prognostic immune-related genes in hepatocellular carcinoma","volume":"2021","author":"Qin","year":"2021","journal-title":"J. Healthc. Eng."},{"key":"10.1016\/j.bbadis.2026.168433_bb0170","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.18632\/aging.205832","article-title":"Identification of a novel matrix metalloproteinases-related prognostic signature in hepatocellular carcinoma","volume":"16","author":"Yuan","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbadis.2026.168433_bb0175","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.omtn.2021.10.025","article-title":"PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2","volume":"26","author":"Chang","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.bbadis.2026.168433_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15522","article-title":"Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex","volume":"8","author":"Teng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168433_bb0185","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/cam4.2115","article-title":"PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing","volume":"8","author":"Mao","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbadis.2026.168433_bb0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13046-018-0736-0","article-title":"PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168433_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1012121","article-title":"Oocyte vitrification disrupts zygotic genome activation in embryos by impairing maternal spliceosome translation and Crxos splicing","volume":"22","author":"Qin","year":"2026","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2026.168433_bb0200","article-title":"De novo PHF5A variants are associated with craniofacial abnormalities, developmental delay, and hypospadias","volume":"25","author":"Harms","year":"2023","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbadis.2026.168433_bb0205","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1101\/gad.5.12a.2303","article-title":"The product of the yeast UPF1 gene is required for rapid turnover of mRNAs containing a premature translational termination codon","volume":"5","author":"Leeds","year":"1991","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2026.168433_bb0210","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/nar\/25.4.814","article-title":"Cloning and characterization of HUPF1, a human homolog of the Saccharomyces cerevisiae nonsense mRNA-reducing UPF1 protein","volume":"25","author":"Applequist","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2026.168433_bb0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0168-9525(98)01658-8","article-title":"RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer","volume":"15","author":"Culbertson","year":"1999","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbadis.2026.168433_bb0220","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1038\/onc.2017.172","article-title":"Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance","volume":"36","author":"Song","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168433_bb0225","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1002\/1878-0261.13076","article-title":"Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2","volume":"15","author":"Sun","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168433_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13741","article-title":"Splicing control by PHF5A is crucial for melanoma cell survival","volume":"58","author":"Meissgeier","year":"2025","journal-title":"Cell Prolif."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:25:17Z","timestamp":1790987117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926002991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926002991"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168433","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSMD14 promotes hepatocellular carcinoma cell proliferation through E2F4-dependent PHF5A transcription and alternative splicing","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168433"}}